Enoximone
Back to searchMolecule Structure
Scientific Name
Enoximone
Description of the Drug
Enoximone is a selective phosphodiesterase inhibitor indicated in the short term treatment of congestive heart failure.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB04880
http://www.drugbank.ca/drugs/DB04880
Brand Name(s)
Perfan
Company Owner(s)
Not Available
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Phosphodiesterase 3 | PROTEIN FAMILY | INHIBITOR | CHEMBL2094125 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL44049 |
PharmGKB | PA164768794 |
Human Metabolome Database | HMDB0015599 |
DrugBank | DB04880 |
PubChem: Thomson Pharma | 14749775 |
PubChem | 53708 |
Nikkaji | J22.780C |
BindingDB | 50241379 |
EPA CompTox Dashboard | DTXSID8045147 |
DrugCentral | 1014 |
ChemicalBook | CB2682723 |
Guide to Pharmacology | 9063 |
rxnorm | ENOXIMONE |
PubChem: Drugs of the Future | 12012687 |
ChEBI | 135010 |
ZINC | ZINC000009225358 |